Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival

SIMPLE SUMMARY: Long-term immunosuppressive therapy following liver transplantation is associated with an increased risk for the development of de novo lung carcinoma. However, data on the management of the immunosuppression following the diagnosis of lung cancer are missing to the present day. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesthy, Sina, Wegener, Elisa, Ossami Saidy, Ramin Raul, Timmermann, Lea, Uluk, Deniz, Aydin, Mustafa, Dziodzio, Tomasz, Schoening, Wenzel, Lurje, Georg, Öllinger, Robert, Frost, Nikolaj, Fehrenbach, Uli, Rückert, Jens-Carsten, Neudecker, Jens, Pratschke, Johann, Eurich, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179580/
https://www.ncbi.nlm.nih.gov/pubmed/35681728
http://dx.doi.org/10.3390/cancers14112748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179580/
https://www.ncbi.nlm.nih.gov/pubmed/35681728
http://dx.doi.org/10.3390/cancers14112748

Ejemplares similares